UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 29, 2005
QUIDEL CORPORATION
(Exact Name of Registrant as Specified in its Charter)
|
Delaware |
|
0-10961 |
|
94-2573850 |
|
|
(State or Other
Jurisdiction |
|
(Commission |
|
(IRS Employer |
|
|
|
|
|
|
|
|
|
10165 McKellar Court |
|
|
|
||
|
San Diego, California |
|
92121 |
|
||
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
|
||
Registrant’s telephone number, including area code: (858) 552-1100
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On December 29, 2005, Quidel Corporation (the “Company”) issued a press release announcing its receipt of FDA clearance for new claims for its QuickVue® Influenza A+B test and projecting a strong finish for the Company’s fiscal year ending December 31, 2005. A copy of the Company’s press release is attached as Exhibit 99.1 hereto.
The information in this current report on Form 8-K, including the exhibit attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section. The information in this current report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibit is furnished with this current report on Form 8-K:
|
Exhibit Number |
|
Description of Exhibit |
|
|
|
|
|
99.1 |
|
Press release, dated December 29, 2005. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Date: December 29, 2005 |
|||
|
|
QUIDEL CORPORATION |
|||
|
|
|
|||
|
|
|
|||
|
|
By: |
/s/ Paul E. Landers |
|
|
|
|
Name: |
Paul E. Landers |
|
|
|
|
Its: |
Senior Vice President, Chief Financial |
||
3
EXHIBIT INDEX
|
Exhibit Number |
|
Description of Exhibit |
|
|
|
|
|
99.1 |
|
Press release, dated December 29, 2005. |
4